Angela Stoehr
Obstetrics & Gynecology · Frisco, TXNPI 1144420167
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Pacira Pharmaceuticals Incorporated accounts for 97.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $32,394 and has fallen 99.7% since, to $107 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $318.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$120K
- AbbVie$515
- Coopersurgical, Inc.$344
- Sumitomo Pharma America, Inc.$266
- AMAG Pharmaceuticals, Inc.$213
- Therapeuticsmd, Inc.$198
- plus $1K from 21 others
What the payments were for
- Consulting fees$27,12422%
- Speaking & faculty fees$59,63549%
- Travel & lodging$28,50523%
- Food & beverage$7,2616%
- Education$2130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 282 | $119,996 |
| AbbVie | 37 | $515 |
| Coopersurgical, Inc. | 5 | $344 |
| Sumitomo Pharma America, Inc. | 7 | $266 |
| AMAG Pharmaceuticals, Inc. | 4 | $213 |
| Therapeuticsmd, Inc. | 6 | $198 |
| Minerva Surgical, Inc | 2 | $168 |
| Axonics, Inc. | 3 | $161 |
| Exeltis, USA Inc. | 6 | $115 |
| Bluewind Medical | 2 | $110 |
| Gynesonics, Inc. | 1 | $103 |
| Daiichi Sankyo Inc. | 4 | $69 |
| Pfizer | 3 | $55 |
| Organon | 3 | $53 |
| Hologic Sales And Service, LLC | 3 | $51 |
| Vertical Pharmaceuticals, LLC | 2 | $47 |
| Dexcom, Inc. | 2 | $39 |
| Sage Therapeutics, LLC | 2 | $32 |
| Abbott | 2 | $32 |
| Millicent US Inc | 1 | $28 |
| Exact Sciences | 2 | $27 |
| Mimedx Group, Inc. | 1 | $25 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Bayer | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Aspira Women's Health Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$115,613
- Zilretta$5,558
- Iovera$1,200
- Uterine Manipulators & Injectors$225
- Axonics$126
- MYFEMBREE$125
- IMVEXXY$124
- INTRAROSA$122
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$103
How this compares
$122,739 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 11 | $639 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Frisco
- Paul MeggsFrisco$253K
- Heather BartosFrisco$47K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.